DOCSLIB.ORG

Formal Semisynthesis of Demethylgorgosterol Utilizing A

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Formal Semisynthesis of Demethylgorgosterol Utilizing A Full Papers doi.org/10.1002/ejoc.202100035 1 2 3 Formal Semisynthesis of Demethylgorgosterol Utilizing a 4 5 Stereoselective Intermolecular Cyclopropanation Reaction 6 [a] [a] [a, e] [b] [c] 7 Nicolai Rosenbaum, Lisa Schmidt, Florian Mohr, Olaf Fuhr, Martin Nieger, and [a, d] 8 Stefan Bräse* 9 10 11 In this study, we report a convenient and high yielding formal ester shows a trans/cis ratio of 89:11, with a diastereomeric 12 semisynthesis of demethylgorgosterol, a marine steroid with an ratio for the trans-diastereomers of >99:1. A reduction/ 13 intriguing sidechain containing a cyclopropane unit. This was oxidation sequence afforded the corresponding aldehyde, 14 achieved through the synthesis of an advanced ketone which was used in a Grignard reaction. A final oxidation step 15 intermediate. The synthetic route features a total of ten steps, then yielded the desired ketone. This novel route presents a 16 starting from commercially available stigmasterol, with an platform to further investigate the medicinal applications of 17 overall yield of 27%. The key step was a stereoselective gorgosterol-type steroids and to fully understand their role in 18 intermolecular cyclopropanation reaction. This reaction pro- coral symbiosis. 19 ceeded in 82% yield, the resulting cyclopropane carboxylic 20 21 Introduction One of these many natural products, gorgosterol (1a), was 22 first isolated by Bergmann et al. in 1943 from the soft coral 23 Corals and coral reefs, despite only covering about 1% of the Plexaura flexuosa.[7] Gorgosterol is also found in various other 24 ocean floor, are the most diverse aquatic ecosystems.[1] They are animals and their symbionts.[8] It had chemists puzzled due to 25 associated with an estimated 25% of all marine species and its unusual properties,[7,9] until its structure was elucidated 26 rivaled in biodiversity only by rain forests.[2] Their ecological, as unambiguously,[10] and its first derivative demethylgorgosterol 27 well as economic impact, is of global scale,[3] and they are a (1b) was discovered.[11] Nowadays, a plethora of derivatives are 28 source of countless natural products.[4] Yet, they are endangered known, e.g. 2–5 (Figure 1), showing a multitude of biological 29 by climate change in multiple ways,[5] as well as by environ- activities.[12] These include cytotoxicity against various cancer 30 mental pollution,[5a] amongst others.[6] cell lines,[12c,13] reversal of multidrug resistance in cancer cells,[14] 31 antitubercular activity[15], and antifungal activity.[16] A common 32 feature of these steroids is their distinctive sidechain, containing 33 [a] N. Rosenbaum, L. Schmidt, Dr. F. Mohr, Prof. Dr. S. Bräse 34 Institute of Organic Chemistry (IOC) Karlsruhe Institute of Technology (KIT) 35 Fritz-Haber-Weg 6, 76131 Karlsruhe, Germany 36 E-mail: braese@kit.edu 37 http://www.ioc.kit.edu/braese/index.php [b] Dr. O. Fuhr 38 Institute for Nanotechnology (INT) and Karlsruhe Nano Micro Facility 39 (KNMF) 40 Karlsruhe Institute of Technology (KIT) Hermann-von-Helmholtz Platz 1, 76344 Eggenstein-Leopoldshafen 41 [c] Dr. M. Nieger 42 Department of Chemistry 43 University of Helsinki P. O. Box 55, 00014 Helsinki, Finland 44 [d] Prof. Dr. S. Bräse 45 Institute of Biological and Chemical Systems – Functional Molecular 46 Systems (IBCS-FMS) Karlsruhe Institute of Technology (KIT) 47 Hermann-von-Helmholtz Platz 1, 76344 Eggenstein-Leopoldshafen 48 https://fms.ibcs.kit.edu 49 [e] Dr. F. Mohr New address: Pharmazeutisches Institut 50 Eberhard-Karls-Universität Tübingen 51 Auf der Morgenstelle 8, 72076 Tübingen 52 Supporting information for this article is available on the WWW under https://doi.org/10.1002/ejoc.202100035 53 © 2021 The Authors. European Journal of Organic Chemistry published by 54 Wiley-VCH GmbH. This is an open access article under the terms of the 55 Creative Commons Attribution Non-Commercial License, which permits use, Figure 1. Structures of Gorgosterol (1a), Demethylgorgosterol (1b), and 56 distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. selected derivatives 2–5. 57 Eur. J. Org. Chem. 2021, 1568–1574 1568 © 2021 The Authors. European Journal of Organic Chemistry published by Wiley-VCH GmbH Wiley VCH Donnerstag, 04.03.2021 2110 / 192789 [S. 1568/1574] 1 Full Papers doi.org/10.1002/ejoc.202100035 a C22/C23 cyclopropane ring and additional methyl groups at then cyclized to yield the known aldehyde 12 (Scheme 1c). 1 C23 and C24. These routes, despite involving more steps, produced the 2 The exact mechanism of the biosynthesis of the gorgosterol intermediary ketone 8 in a higher yield.[18] Ikekawa et al. also 3 family has not been fully elucidated yet. Several plausible routes presented a stereoselective semisynthesis of gorgosterol (1b) 4 have been proposed and discussed, with no final conclusion.[19] using a similar 3-exo-tet cyclization.[24] 5 However, biosynthesis is believed to be part of the complex 6 symbiotic relationship between corals and algae. Recently, it 7 was shown that corals depend on sterols provided by their Results and Discussion 8 symbionts and that their sterol composition varies substantially 9 to symbiont species and even cell line.[20] The biological The starting point for our semisynthesis was the commercially 10 function of gorgosterol is unknown, but it exhibits activity as a available stigmasterol (6). The latter phytosterol was trans- 11 growth inhibitor of human colon tumor cell lines.[21] Addition- formed into the alkene 19, which was needed for the enantio- 12 ally, it was identified as a new chemotype of farnesoid-X- and diastereoselective intermolecular cyclopropanation, accord- 13 receptor (FXR) antagonist,[12d] making it a potential target for ing to known procedures in five steps (Scheme 2). The first two 14 the treatment of cholestasis.[22] steps were necessary to protect the steroidal A- and B-rings in 15 In the past, several semisyntheses of demethylgorgosterol the form of the i-steroid methyl ether 16.[25] This was followed 16 (1b) and its stereoisomers, as well as one of gorgosterol (1a), by the cleavage of the side chain by ozonolysis,[26] and 17 were achieved by the groups of Djerassi and Ikekawa. The first subsequent transformation of the resulting aldehyde 17.[23] A 18 attempts to methylenate a suitable precursor using either a Julia-like, two-step alkene synthesis was employed, rather than 19 Simmons-Smith reaction or a Corey-Chaykovsky reaction did one step procedures like the Wittig reaction, since this resulted 20 not yield the desired configuration.[23] All of the following in higher yields.[27] Alkene 19 was obtained from stigmasterol 21 syntheses used an intramolecular 3-exo-tet ring-closure strategy (6) in up to 52% yield on a multi-gram scale. 22 to form the cyclopropane moiety in the desired configuration Since rhodium-based catalysts often show poor selectivity 23 (Scheme 1). The shortest route, developed by Djerassi et al., and yields for the cyclopropanation of aliphatic alkenes,[28] and 24 consists of a total of 15 steps. The key step was a domino asymmetric Corey-Chaykovsky- and Simmons-Smith-type reac- 25 cyclization/alkylation-reaction of 7 to 8 (Scheme 1a). However, tions were chemically not applicable to alkene 19, we opted for 26 the overall yield of the above-mentioned semisynthesis was Iwasa’s ruthenium-based procedure.[29] From their model for the 27 very low.[17] Ikekawa et al. developed three different routes, all chiral induction in this Ru-pheox catalyzed cyclopropanation we 28 leading to ketone 8 eventually and converging into Djerassi’s deduced that the (R)-configured catalyst would produce the 29 route. Starting from steroid 9, which was transformed into desired stereochemistry. The ligand 21 and catalyst 22 were 30 aldehyde 11 and then cyclized yielding 12. The cyclized synthesized according to literature from (R)-2-phenylglycinol 31 aldehyde 12 was then transformed into the known ketone 8 (20) in yields of 73% and 88% respectively (Scheme 3).[30] 32 (Scheme 1b).[18a] Alternatively, starting material 13 could either Scheme 4 shows the cyclopropanation carried out under 33 be transformed into 10 to join route (b) or into 14, which was optimized reaction conditions. A yield of 82% was achieved, 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 Scheme 1. Previous semisyntheses of demethylgorgosterol (1b). Routes developed by (a) Djerassi et al.[17] and (b), (c) Ikekawa et al.[18] 57 Eur. J. Org. Chem. 2021, 1568–1574 www.eurjoc.org 1569 © 2021 The Authors. European Journal of Organic Chemistry published by Wiley-VCH GmbH Wiley VCH Donnerstag, 04.03.2021 2110 / 192789 [S. 1569/1574] 1 Full Papers doi.org/10.1002/ejoc.202100035 1 2 3 4 5 6 7 8 9 10 Scheme 2. Synthesis of the alkene 19 starting from commercially available stigmasterol (6). Reaction conditions: a) TsCl, pyridine, rt, 16 h, quant. b) MeOH, 11 pyridine, reflux, 4 h, 78 %. c) i) O3, DCM, MeOH, À 78 °C, 45 min; ii) Zn, HOAc, rt, 1 h, 80 %. d) TsNHNH2, MS 3 Å, ethanol, rt, 30 min, 50 °C, 30 min, 95%. 12 e) Dimethyl sulfone, nBuLi, THF, 0 °C to rt, 16 h, 88%. 13 14 15 16 17 18 19 20 21 Scheme 3. Synthesis of (R)-Ru-pheox 22 from (R)-2-phenylglycinol (20). Reaction conditions: a) i) benzoyl chloride, Et N, DCM, 0 °C to rt, 16 h. 22 3 ii) SOCl2, CHCl3, 0 °C to rt, 24 h. iii) 2.5 m NaOH, 1,4-dioxan, 0 °C to rt, 4 h, 23 73%. b) benzeneruthenium(II) chloride dimer, 1 m NaOH, KPF6, MeCN, 80 °C, 24 48 h, 88 %.
Load more

Recommended publications
  • Hans Renata – Strategic Redox Relay Enables a Scalable Synthesis Of
    Strategic Redox Relay Enables A Scalable Synthesis of Ouabagenin, A Bioactive Cardenolide A thesis presented by Hans Renata to The Scripps Research Institute Graduate Program in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the subject of Chemistry for The Scripps Research Institute La Jolla, California February 2013 UMI Number: 3569793 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. UMI 3569793 Published by ProQuest LLC (2013). Copyright in the Dissertation held by the Author. Microform Edition © ProQuest LLC. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, MI 48106 - 1346 © 2013 by Hans Renata All rights reserved ! ii! ACKNOWLEDGEMENTS To Phil, thank you for taking me under your wing, the past five years have been a wonderful learning experience. You truly are a fantastic teacher, both in and out of the fumehood and your unbridled enthusiasm, fearlessness and passion for chemistry are second to none. In the words of Kurt Cobain, I am “forever indebted to your priceless advice.” To the members of the Baran lab, in the words of Kurt Cobain, “Our little (?) group has always been and always will until the end.” See what I did there? Oh well, whatever, nevermind.
    [Show full text]
  • Peptide Chemistry up to Its Present State
    Appendix In this Appendix biographical sketches are compiled of many scientists who have made notable contributions to the development of peptide chemistry up to its present state. We have tried to consider names mainly connected with important events during the earlier periods of peptide history, but could not include all authors mentioned in the text of this book. This is particularly true for the more recent decades when the number of peptide chemists and biologists increased to such an extent that their enumeration would have gone beyond the scope of this Appendix. 250 Appendix Plate 8. Emil Abderhalden (1877-1950), Photo Plate 9. S. Akabori Leopoldina, Halle J Plate 10. Ernst Bayer Plate 11. Karel Blaha (1926-1988) Appendix 251 Plate 12. Max Brenner Plate 13. Hans Brockmann (1903-1988) Plate 14. Victor Bruckner (1900- 1980) Plate 15. Pehr V. Edman (1916- 1977) 252 Appendix Plate 16. Lyman C. Craig (1906-1974) Plate 17. Vittorio Erspamer Plate 18. Joseph S. Fruton, Biochemist and Historian Appendix 253 Plate 19. Rolf Geiger (1923-1988) Plate 20. Wolfgang Konig Plate 21. Dorothy Hodgkins Plate. 22. Franz Hofmeister (1850-1922), (Fischer, biograph. Lexikon) 254 Appendix Plate 23. The picture shows the late Professor 1.E. Jorpes (r.j and Professor V. Mutt during their favorite pastime in the archipelago on the Baltic near Stockholm Plate 24. Ephraim Katchalski (Katzir) Plate 25. Abraham Patchornik Appendix 255 Plate 26. P.G. Katsoyannis Plate 27. George W. Kenner (1922-1978) Plate 28. Edger Lederer (1908- 1988) Plate 29. Hennann Leuchs (1879-1945) 256 Appendix Plate 30. Choh Hao Li (1913-1987) Plate 31.
    [Show full text]
  • Identification of a Thioesterase Bottleneck in the Pikromycin Pathway Through Full-Module Processing of Unnatural Pentaketides
    Article pubs.acs.org/JACS Identification of a Thioesterase Bottleneck in the Pikromycin Pathway through Full-Module Processing of Unnatural Pentaketides † ‡ † § † ‡ ⊥ ∥ Douglas A. Hansen, , Aaron A. Koch, , and David H. Sherman*, , , , † ‡ § ⊥ Life Sciences Institute, Department of Medicinal Chemistry, Cancer Biology Graduate Program, Department of Chemistry, and ∥ Department of Microbiology & Immunology, University of Michigan, Ann Arbor, Michigan 48109, United States *S Supporting Information ABSTRACT: Polyketide biosynthetic pathways have been engineered to generate natural product analogs for over two decades. However, manipulation of modular type I polyketide synthases (PKSs) to make unnatural metabolites commonly results in attenuated yields or entirely inactive pathways, and the mechanistic basis for compromised production is rarely elucidated since rate-limiting or inactive domain(s) remain unidentified. Accordingly, we synthesized and assayed a series of modified pikromycin (Pik) pentaketides that mimic early pathway engineering to probe the substrate tolerance of the PikAIII-TE module in vitro. Truncated pentaketides were processed with varying efficiencies to corresponding macrolactones, while pentaketides with epimerized chiral centers were poorly processed by PikAIII-TE and failed to generate 12-membered ring products. Isolation and identification of extended but prematurely offloaded shunt products suggested that the Pik thioesterase (TE) domain has limited substrate flexibility and functions as a gatekeeper in the processing of
    [Show full text]
  • Enantioselective, Convergent Synthesis of the Ineleganolide Core by a Tandem Annulation Cite This: Chem
    Chemical Science View Article Online EDGE ARTICLE View Journal | View Issue Enantioselective, convergent synthesis of the ineleganolide core by a tandem annulation Cite this: Chem. Sci.,2017,8,507 cascade† Robert A. Craig, II, Jennifer L. Roizen, Russell C. Smith, Amanda C. Jones, Scott C. Virgil and Brian M. Stoltz* An enantioselective and diastereoselective approach toward the synthesis of the polycyclic norditerpenoid ineleganolide is disclosed. A palladium-catalyzed enantioselective allylic alkylation is employed to stereoselectively construct the requisite chiral tertiary ether and facilitate the synthesis of a 1,3-cis- cyclopentenediol building block. Careful substrate design enabled the convergent assembly of the ineleganolide [6,7,5,5]-tetracyclic scaffold by a diastereoselective cyclopropanation–Cope rearrangement cascade under unusually mild conditions. Computational evaluation of ground state energies of late-stage synthetic intermediates was used to guide synthetic development and aid in the Creative Commons Attribution 3.0 Unported Licence. investigation of the conformational rigidity of these highly constrained and compact polycyclic structures. This work represents the first successful synthesis of the core structure of any member of the furanobutenolide-derived polycyclic norcembranoid diterpene family of natural products. Advanced Received 28th July 2016 synthetic manipulations generated a series of natural product-like compounds that were shown to Accepted 15th August 2016 possess selective secretory antagonism of either interleukin-5 or interleukin-17. This bioactivity stands in DOI: 10.1039/c6sc03347d contrast to the known antileukemic activity of ineleganolide and suggests the norcembranoid natural www.rsc.org/chemicalscience product core may serve as a useful scaffold for the development of diverse therapeutics. This article is licensed under a Introduction this rigid polycyclic scaffold is decorated with a network of nine stereogenic centers, eight of which are contiguous.
    [Show full text]
  • Subtiligase: a Tool for Semisynthesis of Proteins THOMAS K
    Proc. Natl. Acad. Sci. USA Vol. 91, pp. 12544-12548, December 1994 Biochemistry Subtiligase: A tool for semisynthesis of proteins THOMAS K. CHANG*t, DAVID Y. JACKSON*, JOHN P. BURNIERt, AND JAMES A. WELLS*§ Departments of *Protein Engineering and tBioOrganic Chemistry, Genentech, Inc., 460 Point San Bruno Boulevard, South San Francisco, CA 94080 Communicated by Harry B. Gray, August 1, 1994 ABSTRACT A variant of subtilisin BPN', which we call phenylalanylamide (glc-F-amide) were synthesized as de- subtiligase, has been used to ligate esterified peptides site- scribed (15). For ligations onto immobilized supports, pep- specifically onto the N termini of proteins or peptides in tides were synthesized on 96-well (---0.17 nmol per well) aqueous solution and in high yield. We have produced biotin- CovaLink ELISA plates (Nunc) by using N-(9-fluorenyl- ylated or heavy-atom derivatives ofmethionyl-extended human methoxycarbonyl) (Fmoc)-protected amino acids and dicyc- growth hormone (Met-hGH) by ligating it onto synthetic pep- lohexylcarbodiimide (DCC) activation in dimethyl sulfoxide tides containing biotin or mercury. Polyethylene glycol (PEG)- (DMSO). The plates were washed with 5% piperidine in modified atrial natriuretic peptide (ANP) was produced by methanol to neutralize the amino linkers and incubated with ligating ANP onto peptides containing sites for PEG modifi'ca- 100 /,u of DMSO containing 1 mM Fmoc-Ala and 0.5 mM tion. We have established the N-terminal sequence require- DCC for 10 min at 25°C. The plates were washed with DMSO, ments for efficient ligation onto proteins, using either synthetic and the Fmoc protecting groups were removed with 5% substrates or pools of ifiamentous phage containing Met-hGH piperidine in methanol.
    [Show full text]
  • NIH Public Access Author Manuscript J Am Chem Soc
    NIH Public Access Author Manuscript J Am Chem Soc. Author manuscript; available in PMC 2013 October 10. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: J Am Chem Soc. 2012 October 10; 134(40): 16781–16790. doi:10.1021/ja307220z. Identification and Characterization of the Echinocandin B Biosynthetic Gene Cluster from Emericella rugulosa NRRL 11440 Ralph A. Cacho1, Wei Jiang3, Yit-Heng Chooi1, Christopher T. Walsh3,*, and Yi Tang1,2,* 1Department of Chemical and Biomolecular Engineering, University of California, Los Angeles, 420 Westwood Plaza, Los Angeles, CA 90095 2Department of Chemistry and Biochemistry, University of California, Los Angeles, 607 Charles E. Young Drive East, Los Angeles, CA 90095 3Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 200 Longwood Ave, Boston, MA 02115 Abstract Echinocandins are a family of fungal lipidated cyclic hexapeptide natural products. Due to their effectiveness as antifungal agents, three semisynthetic derivatives have been developed and approved for treatment of human invasive candidiasis. All six of the amino acid residues are hydroxylated, including 4R,5R-dihydroxy-L-ornithine, 4R-hydroxyl-L-proline, 3S,4S-dihydroxy- L-homotyrosine, and 3S-hydroxyl,4S-methyl-L-proline. We report here the biosynthetic gene cluster of echinocandin B 1 from Emericella rugulosa NRRL 11440 containing genes encoding for a six-module nonribosomal peptide synthetase EcdA, an acyl-AMP ligase EcdI and oxygenases EcdG, EcdH and EcdK. We showed EcdI activates linoleate as linoleyl-AMP and installs it on the first thiolation domain of EcdA. We have also established through ATP:PPi exchange assay that EcdA loads L-ornithine in the first module.
    [Show full text]
  • AP Biology: Chemistry B Mcgraw Hill AP Biology 2014-15 Contents
    AP Biology: Chemistry B McGraw Hill AP Biology 2014-15 Contents 1 Carbohydrate 1 1.1 Structure .................................................. 1 1.2 Monosaccharides ............................................. 2 1.2.1 Classification of monosaccharides ................................ 2 1.2.2 Ring-straight chain isomerism .................................. 3 1.2.3 Use in living organisms ...................................... 3 1.3 Disaccharides ............................................... 3 1.4 Nutrition .................................................. 4 1.4.1 Classification ........................................... 5 1.5 Metabolism ................................................ 5 1.5.1 Catabolism ............................................ 5 1.6 Carbohydrate chemistry .......................................... 5 1.7 See also .................................................. 6 1.8 References ................................................. 6 1.9 External links ............................................... 7 2 Lipid 8 2.1 Categories of lipids ............................................ 8 2.1.1 Fatty acids ............................................. 8 2.1.2 Glycerolipids ........................................... 9 2.1.3 Glycerophospholipids ....................................... 9 2.1.4 Sphingolipids ........................................... 9 2.1.5 Sterol lipids ............................................ 10 2.1.6 Prenol lipids ............................................ 10 2.1.7 Saccharolipids ..........................................
    [Show full text]
  • Methyltransferases of Gentamicin Biosynthesis
    Methyltransferases of gentamicin biosynthesis Sicong Lia,1, Junhong Guoa,1, Anna Revab, Fanglu Huangb, Binbin Xionga, Yuanzhen Liua, Zixin Denga,c, Peter F. Leadlayb,2, and Yuhui Suna,2 aKey Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, People’s Republic of China; bDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, United Kingdom; and cState Key Laboratory of Microbial Metabolism, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, People’s Republic of China Edited by Caroline S. Harwood, University of Washington, Seattle, WA, and approved December 26, 2017 (received for review June 30, 2017) Gentamicin C complex from Micromonospora echinospora re- G418 (5) to gentamicin components C2a, C2, and C1. The mains a globally important antibiotic, and there is revived in- full mechanistic details of the subsequent transamination and terest in the semisynthesis of analogs that might show improved dehydroxylation steps remain to be clarified, although the de- therapeutic properties. The complex consists of five compo- hydrogenase GenQ (20), phosphotransferase GenP, and the nents differing in their methylation pattern at one or more sites pyridoxal-dependent enzymes GenB1, GenB2, GenB3, and in the molecule. We show here, using specific gene deletion and GenB4 have all been implicated in this enigmatic process (20, 25, chemical complementation, that the gentamicin pathway up to 26). Finally, the terminal step in both branches of the pathway the branch point is defined by the selectivity of the methyl- involves the (partial) conversion of C1a into C2b and of C2 transferases GenN, GenD1, and GenK.
    [Show full text]
  • Natural Products. a History of Success and Continuing Promise for Drug Discovery and Development
    Natural Products. A History of Success and Continuing Promise for Drug Discovery and Development Gordon M. Cragg NIH Special Volunteer gmcragg@verizon.net David J. Newman Natural Products Branch Developmental Therapeutics Program National Cancer Institute EARLY DOCUMENTATION OF USE OF MEDICINAL PLANTS http://www.nlm.nih.gov/hmd/collections/archives/index.html • Mesopotamian ~2,600 B. C. E. • Egyptian ~ 1,800 B. C. E. • Chinese – ~1,100 B. C. E. and continuing • Indian ~ 1,000 B. C. E. and continuing • Greek ~ 500 B. C. E. Greco-Roman expertise preserved and coordinated with other traditions by Islamic cultures during the Dark Ages ~ 400-1,100 CE Avicenna. Persian pharmacist, physician, poet, philosopher author: canon medicinae – “final codification of Greco-Roman medicine” Great Moments in Pharmacy Collection APhA Traditional Medicine and Drug Discovery • 80% of the world population resides in developing countries • 80% of people in developing countries utilize plants to meet their primary health care needs • Global pop. ca. 7 billion ca. 4.5 billion people utilize plants to meet their primary health care needs Farnsworth NR, et al. Medicinal Plants in Therapy. Bull. W.H.O. 63:965-981 (1985) Fabricant and Farnsworth, EnViron. Health Perspect. 109, 69-75 (2001) Cordell and Clovard, J. Nat. Prod., 75, 514-525 (2012) Norman Farnsworth 1800s. Discovery of some active principles of major herbal preparations Newman and Cragg. Natural Product Chemistry for Drug Discovery, eds. Buss and Butler, M. S., Royal Soc. Chem., Cambridge, 2010, pp. 3-27 European chemists (apothecaries) revolutionized drug discovery and development. 1817. Sertϋrner reports isolation of morphine from Papaver somniferum.
    [Show full text]
  • Development of a Four-Step Semi-Biosynthesis of the Anticancer Drug Paclitaxel and Its Analogues
    DEVELOPMENT OF A FOUR-STEP SEMI-BIOSYNTHESIS OF THE ANTICANCER DRUG PACLITAXEL AND ITS ANALOGUES By Chelsea Thornburg A DISSERTATION Submitted to Michigan State University in partial fulfillment of the requirements for the degree of Biochemistry and Molecular Biology ‒ Doctor of Philosophy 2015 ABSTRACT DEVELOPMENT OF A FOUR-STEP SEMI-BIOSYNTHESIS OF THE ANTICANCER DRUG PACLITAXEL AND ITS ANALOGUES By Chelsea Thornburg Paclitaxel (Taxol®) is a widely used chemotherapeutic drug with additional medical applications in drug-eluting stents as an anti-restenosis treatment. Paclitaxel is a structurally complex natural product with an excellent scaffold for designing analogs with pharmacological properties. To date, clinically approved analogs include docetaxel and cabazitaxel for the treatment of additional cancers. Currently, plant cell fermentation methods produce paclitaxel and large quantities of the precursors 10-deacetylbaccatin III (10-DAB) and baccatin III. The complexity of the semi-characterized ~19-step paclitaxel biosynthetic pathway limits bioengineering attempts. However, the availability of 10-DAB and baccatin III suggests a semi-biosynthetic pathway to paclitaxel starting with these precursors is feasible. We have designed a short, simple biosynthetic pathway, capable of making paclitaxel, analogs, and/or valuable precursors for the semi-synthesis of additional analogs of biological interest. The paclitaxel biosynthesis enzyme baccatin III: 3-amino-13-O-phenylpropanoyl CoA transferase (BAPT) and the bacterial (2R,3S)-phenylisoserinyl CoA ligase (PheAT) produce N-debenzoylpaclitaxel, N-debenzoyldocetaxel, or precursor analogs. The addition of the paclitaxel biosynthetic N-debenzoyltaxol-N-benzoyltransferase (NDTNBT) and the bacterial benzoate CoA ligase (BadA) produce paclitaxel or other N-acylated analogs. In this dissertation, BAPT and BadA are kinetically characterized.
    [Show full text]
  • Semi-Synthesis Jason Green
    Baran Group Meeting Semi-Synthesis Jason Green "Enantioselective Synthesis: Natural Products from Chiral Terpenes" Tse-Lok Ho 1. mCPBA hν O 2. HIO6 3. PhMgBr O OH O 4. PCC I2; OH OH t-BuOK O dihydrocarvone 5. HCO2Et O OH 6. NaIO OtBu 4 O aq. MeOH from citronellal H , Pd/C; I 2 Ph3P=CH2; O O Li0, EtNH 2 OH NC axisonitrile HO O O O Caine, D. J. Am. Chem. Soc. 1978, 100, 8030 OH OH ambruticin Ireland, R. E. J. Am. Chem. Soc. 1980, 102, 6178 OTMS TMSO hν O O + O3; HCl, AlCl3; O TMSO H OTMS O NaOH NaOH piperitone limonene O 215 °C HO HO benzene O3; O O OH NaOH O O daucene chrysanthemic acid Ho, T. L. Synth. Commun. 1982, 12, 995 Audenaert, F. Tetrahedron 1987, 43, 5593 Baran Group Meeting Semi-Synthesis Jason Green O O aq. NH Br 3 H H HBr; Br THF, 0 °C; H HBr; Br O t-BuOK steam Br H 2 O distillation O perillaldehyde O carvone mechanism TsO OH Al2O3; H HO C Ph3P=CH2 H 2 CHO aromadendrene I H HO Buchi, G. J. Am. Chem. Soc. 1966, 88, 4113 sordaricin Wallach, O. Liebigs, Ann. Chem. 1899, 305, 245 Mander, L. N. J. Org. Chem. 1991, 56, 3959 Br2; HN3 BF •OEt ; NH O 3 2 NH2 CO2H Br2; (COCl)2 C + H LAH CHO N O NaOH OH terpineol N pulegone H O HCO2H NH 20% HCl NH NH OH H 2 N HN HN (-)-hobartine actidine (+)-aristoteline Darbre, T.
    [Show full text]
  • Total Synthesis and Characterization of Breitfussins a and B Akbar Husain Khan Iowa State University
    Iowa State University Capstones, Theses and Graduate Theses and Dissertations Dissertations 2017 Total synthesis and characterization of breitfussins A and B Akbar Husain Khan Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/etd Part of the Organic Chemistry Commons Recommended Citation Khan, Akbar Husain, "Total synthesis and characterization of breitfussins A and B" (2017). Graduate Theses and Dissertations. 16284. https://lib.dr.iastate.edu/etd/16284 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact digirep@iastate.edu. Total synthesis and characterization of breitfussins A and B by Akbar H. Khan A dissertation submitted to the graduate faculty in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Major: Organic Chemistry Program of Study Committee: Jason S. Chen, Major Professor Levi M. Stanley, Major Professor William S. Jenks Arthur Winter Yan Zhao The student author, whose presentation of the scholarship herein was approved by the program of study committee, is solely responsible for the content of this dissertation. The Graduate College will ensure this dissertation is globally accessible and will not permit alterations after a degree is conferred. Iowa State University
    [Show full text]